Thursday, October 31, 2019

Cardiac Tamponade Market : Key Players, Growth, Analysis by 2019 – 2023


Market Highlights:

Cardiac tamponade, is the build-up of fluid in the sac around the heart (pericardium) resulting in pressure and difficulty in compression of the heart. Difficulty in compression of the heart results in reduced blood volume to be pumped by the heart. The symptoms of cardiac tamponade include shortness of breath, weakness, light-headedness, cough, fatigue, swelling of the abdomen, veins in the arms or legs, or other areas, pale skin, or skin that is blue- or gray-tinted, rapid heartbeat, anxiety or restlessness, fainting etc. The causes of cardiac tamponade are cancer, kidney failure, chest trauma, and pericarditis, connective tissue diseases, hypothyroidism, aortic rupture, following cardiac surgery, tuberculosis etc. Cardiac tamponade can be life-threatening if not treated. Risk factors which increases the chances of cardiac tamponade include heart surgery, heart attack, injury to the heart, end-stage lung cancer, radiation therapy to the chest, hypothyroidism, systemic lupus erythematosus etc.

The diagnosis segment of cardiac tamponade especially the non-invasive Magnetic Resonance Imaging (MRI) is growing fast. Magnetic Resonance Imaging (MRI) is the diagnostic test of choice. The surgery segment is led by pericardiocentesis which involves drainage of the fluid by use of a needle. Cardiac tamponade has a frequency of approximately 2 per 10,000 per year in the US.
The market drivers for cardiac tamponade market are increasing cardiac cases such as heart attack, other factors includes cancer, kidney failure, end-stage lung cancer, hypothyroidism, rising screening and penetration of healthcare, growing awareness about cardiac diseases and growing income and healthcare expenditure etc. The market restraints are cost of cardiac tamponade surgery, complications and risk of the surgery, invasive nature of treatment etc.
Global Cardiac tamponade Market Players
Key players profiled in the report are Boston Scientific Corporation, Medtronic, Inc., St. Jude Medical Inc., Hitachi, Ltd., Koninklijke Philips N.V., Siemens Healthcare Private Limited, and Toshiba Medical Systems Corporation, General Electric Company, and others.

Regional Analysis
The Americas accounts for a significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the fastest uptake of new drugs in the US drives the cardiac tamponade market. Also, concentration of major research companies in the developed countries of this region is adding fuel to the market growth. The large US expenditure on healthcare accounting to 16% of GDP also cruises the sale of cardiac tamponade treatment. The large number of specialized cardiac centres in the US also drives the market.
Europe is the second largest market in the world due to high income and healthcare penetration. Europe is led by nations such as Germany and France. UK is expected to be the fastest growing market.
Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing healthcare sector during the forecast period.
Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. The development of large hospitals such as the King Fahd hospital in Riyadh is driving the market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.
Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Cardiac tamponade Market” Research Report – Forecast till 2023.
Segmentation

The global cardiac tamponade market has been segmented on the basis of diagnosis, treatment, and end user.
Based on diagnosis, the market has been segmented as X-ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), coronary angiography, electrocardiogram (EKG), and others.
Based on treatment, the market has been segmented as surgery and drugs. The surgery segment has been sub-segmented as pericardiocentesis, thoracotomy and others. The drugs segment has been sub-segmented as antibiotics, blood volume expanders and others.
Based on the end user, the market has been segmented as hospitals & clinics, academic and research and others.

Wednesday, October 30, 2019

Autoimmune Diseases Market : Key Players, Growth, Analysis by 2019 – 2023


Market Potential and Pitfalls
The global autoimmune disease diagnostics market is likely to experience an upsurge owing to the increased prevalence of autoimmune disease, surging awareness regarding autoimmune diseases, and rising expenditure on healthcare. The increasing spending on R&D activities coupled with the aggressive strategies adopted by the top market players like new product launches along with mergers and acquisitions are anticipated to contribute to the market growth across the globe. For instance, Abbott acquired Alere Inc. in October 2017 for USD 5300 million. The deal will enable Abbott to gain control over USD 7000 million diagnostics sales of Alere Inc. and also strengthen their position in the global market.
The increasing occurrences of several diseases like rheumatoid arthritis and Hashimoto’s thyroiditis are likely to influence the market across the globe. Several initiatives taken by the government regarding autoimmune disease diagnosis are further contributing to its growth. As per the American Autoimmune Related Diseases Association, approximately 50 million people from America are suffering from autoimmune related disorders. Such factors are likely to create immense opportunities to the growth of the market.
On the contrary, the surging false positive results along with the price war among the companies are the top barriers likely to vitiate the market growth to some extent during the appraisal period. Moreover, the dearth of education and experience of the lab personnel in diagnosing certain autoimmune diseases are further estimated to slow down the market growth.
Market Synopsis
Market Research Future (MRFR) asserts that the global autoimmune disease diagnostics market is likely to register a CAGR of 7.6% during the forecast period (2018-2023) owing to an increased prevalence of autoimmune diseases worldwide. Autoimmune disease is considered as a disorder where the body’s own immune system starts to attack the healthy cells in place of the foreign particles and disease-causing agents. Auto antibody test, antinuclear antibody test, complete blood count, C-reactive protein, and erythrocyte sedimentation rate are some of the tests performed for diagnosis of the autoimmune disease.
Global Autoimmune Disease Diagnostics Market: Segmental Analysis
The global autoimmune disease diagnostics market has been segmented on the basis of test type, disease type, and end-user.
By mode of disease type, the global autoimmune disease diagnostics market has been segmented into systemic autoimmune disease, and localized autoimmune disease. Among these, the localized autoimmune disease segment is likely to gain prominence owing to the presence of large procedure volume and higher patient awareness level.
By mode of test type, the global autoimmune disease diagnostics market has been segmented into enzyme-linked immunosorbent assay (ELISA), western blotting, dot blot, double immune diffusion, line blot, counter immune-electrophoresis, multiplex immunoassay, immunofluorescence assays (IFA), agglutination, and others.
By mode of end-users, the global autoimmune disease diagnostics market has been segmented into diagnostics centers, hospitals, research laboratories, and others.
Regional Insights
Geographically, the autoimmune disease diagnostics market span across regions namely, Europe, America, Asia-Pacific, and the Middle East & Africa.
Considering the global scenario, the American region is predicted to command the maximum share in the global market. The region is likely to retain its pole position owing to the surging prevalence of autoimmune diseases like rheumatoid arthritis. Moreover, the rising financial support by the private organizations and governments coupled with the adoption of high advanced technology in this region is anticipated to contribute to the growth of the market. As per a report published by the Arthritis Foundation in 2017, around 91 million Americans were suffering from arthritis, 300000 of them were children.
The European region is predicted to occupy the second spot in the global market owing to the increased automation in the laboratories, rising healthcare industry, and strategies implemented by the top market players like mergers & acquisitions and product launches.
The Asia Pacific region is likely to expand at the fastest growth rate during the assessment period. The growth can be ascribed to the inflating population, rising private-public partnerships for the improvement of the healthcare sector, and surging prevalence of autoimmune disorders in this region.
Industry Updates
March 27, 2019: Eli Lilly is planning to partner with ImmuNext in order to study and develop a preclinical novel potential target for the treatment of autoimmune disease through an up-to-$605 million-plus collaboration.
Competitive Dashboard
The prominent players operating in the global autoimmune disease diagnostics market comprises bioMérieux SA, Siemens Healthcare Private Limited, Beckman Coulter Inc., Bio-rad Laboratories, EUROIMMUN AG, AstraZeneca, Inova Diagnostics Inc., F. Hoffmann-la Roche, Thermo Fisher Scientific, Myriad Genetics Inc., Hemagen Diagnostics Inc., and Trinity Biotech Plc.

Tuesday, October 29, 2019

Anti-Aging Services Market : Key Players, Growth, Analysis by 2019 – 2023


Market Highlights:
Increasing elderly population, growing desire to stay young is one of the most important factors that drive the growth of the anti-aging services market. According to the world health organization (WHO), the proportion of the world's population over 60 years between 2015 and 2050 will nearly double from 12% to 22%. Further, as per WHO estimates by 2020, the number of people aged 60 years and older will outnumber children younger than 5 years and by 2050, 80% of older people will be living in low- and middle-income countries. Besides that, factors such as growing demand for anti-aging drugs and services, the influence of media and fashion industry, increasing disposable income, growing awareness about the aesthetical industry are driving the market for anti-aging services.
On the other hand, the high cost of some of the procedures, and potential side effects of the anti-aging treatments are some of the factors that thwart the growth of the anti-aging services market to an extent.
Global Anti-aging Services Market held a market value of USD 21.39 billion in 2017 and is projected to grow at a CAGR of 5.47% over the forecast period.
Regional Analysis:
Geographically, the Americas is anticipated to dominate the global Anti-aging Services Market owing to the well-developed healthcare infrastructure, high disposable income, high awareness about the body aesthetics, and increasing adoption of the anti-aging services by people in the US. Moreover, the huge influence of the fashion and film industry in the US has played an important role in generating demand for the beauty and aesthetic services including anti-aging. All these factors are responsible for the growth in the region.
Europe is expected to hold the second largest market share in the global Anti-aging Services Market. The market growth in this region is majorly attributed to the growing popularity of aesthetic treatments, a high number of old age people, and increasing acceptance of anti-aging treatments in the region. Similarly, the Asia-Pacific region has observed a rapid growth in the anti-aging services market owing to the growing disposable income and demand for cost-effective anti-aging service. Besides, increasing
beauty consciousness in developing countries and rapidly growing medical tourism industry is also expected to generate growth opportunities in the untapped markets of the Asia-Pacific region. The Middle East & Africa region is anticipated to show minor growth opportunities in the anti-aging services market during the forecast period.

Segmentation:
The global anti-aging services market has been segmented into type of service and service provider.
Based on type of service, the market has been segmented into microdermabrasion, breast augmentation, liposuction, chemical peel, sclerotherapy, intense pulsed light, Botox treatment, dermal fillers, and others. The microdermabrasion segment is expected to account for the largest share in the global anti-aging services market in 2017. This large share is majorly attributed to the wider acceptance of the procedure, increasing acceptance in different regions, better patient compliance and better results as compared to other services. Liposuction segment is projected to hold the second largest market during the forecast period of 2018 to 2023.
Based on service providers, the market has been segmented into hospitals, dermatology clinics, salons, and others. The dermatology clinics segment is expected to account for the largest share in the global anti-aging services market in 2017 followed by hospitals segment. The major share of the dermatology clinics is mainly attributed to the wide range of anti-aging services provided by these specialty clinics and
Based on the regions, the market for hair removal devices is segmented into, the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Anti-aging Services Market in the Americas region has further been segmented into North America and Latin America, where-in the North American market is further divided into the US and Canada.
European Anti-aging Services Market has been segmented into Western Europe and Eastern Europe where-in Western Europe region is further divided into Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The Anti-aging Services Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Anti-aging Services Market in the Middle East & Africa has been segmented into regions such as the Middle East and Africa.
Key Players:
Some of the prominent players in the global anti-aging services market are Allergan Inc., Alma Lasers, Beiersdorf AG, Cutera Inc., Cynosure Inc., Elizabeth Arden, Estee Lauder Inc., Lumenis, Procter & Gamble, Solta Medical Inc., and others.

Monday, October 28, 2019

Thumb Arthritis Market : Key Players, Growth, Analysis by 2019 – 2023

Market Highlights
In thumb arthritis, the cushion-like cartilage inside the CMC joint breaks down, causing the bones to rub against each other. Increasing prevalence of thumb arthritis, growing geriatric and obese population, and rising healthcare expenditure are some of the major factors estimated to drive the market growth during the forecast period. A study was published in the HAND (American Association for Hand Surgery) journal in 2016, according to which the prevalence of the thumb CMC osteoarthritis was estimated to be around 8%-12% in the general population. However, the high cost of the surgical therapeutics along with related complications is estimated to restrain the market growth during the forecast period.
The Global Thumb Arthritis Market is expected to grow at an approximate CAGR of 8.1% during the forecast period.
Segmentation
The global thumb arthritis market is segmented on the basis of type, diagnosis, treatment, and end user. On the basis of the type, the market is segmented into osteoarthritis thumb arthritis, rheumatoid thumb arthritis, and others. On the basis of the diagnosis, the market is segmented into physical examinations, imaging, fine needle aspiration (FNA), and others. The imaging segment is sub-segmented into X-ray, computed tomography (CT), magnetic resonance imaging (MRI), and others.
On the basis of the treatment, the market is segmented into thumb exercise, medication, surgery, and others. The medication segment is sub-segmented into OCT medications, prescription medications, and others. The surgery segment is sub-segmented into trapeziectomy, osteotomy, and others.
On the basis of the end users, the market is segmented into hospitals & clinics, research organizations, retail pharmacies, and others.
Regional Analysis
The Americas dominate the global thumb arthritis market. A well-developed healthcare sector, growing geriatric population, and increasing healthcare expenditure are the major drivers for the growth of the global thumb arthritis market.
Europe holds the second largest thumb arthritis market owing to the availability of the funds for research, increasing surgery adoption rates, and growing patient population. According to the Office for National Statistics the geriatric population within the region is expected to grow and reach 20.5% of the total U.K population by 2026 from 18.0% in 2016.
Asia Pacific is the fastest growing region. Growing geriatric and obese population followed by the developing healthcare sector are boosting the market growth. Within the region, Australia holds a significant ratio of the obese population. However, the presence of the developing economies like India and China are marked by expanding healthcare sector. This is estimated to provide favorable backgrounds for the market growth.
The Middle East and Africa region account for the least market share. This is mainly due to the presence of the poor African economies within the region, which have low per capita income and lack of the medical services. On the other, the Middle East holds the largest market share within the region.

Key Players
The key players in the global thumb arthritis market are inclusive of BioPro (U.S.), McKie Splints (U.S.), AbbVie Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Amgen Inc. (U.S.), Pfizer Inc. (U.S.), Carestream Health. (U.S.), General Electric Company (U.K), and others.

Patellar tendinitis Market size by Industry Insight Analysis, Segments, Top Key Players, Drivers and Trends to 2023


Market Highlights
The people with diabetes and rheumatoid arthritis are more likely to suffer from patellar tendinitis. The patient population suffering from diabetes and rheumatoid arthritis is increasing continuously, which significantly increased the demand for the treatment of the tendinitis drugs. Additionally, adoption of the sedentary lifestyle has fuelled the market growth.
Over the last decade, the total number of hospitals has increased to a great extent, which has influenced the growth of the market positively. Moreover, increasing demand for better treatment and changing reimbursement policies have fueled the market growth.
The global patellar tendinitis market is expected to grow at a CAGR of ~8.1% during the forecast period 2017-2023.
Regional Analysis
The Americas patellar tendinitis market is expected to show an extensive growth owing to increasing number of sports injuries, availability of cost-effective treatment, and flourishing growth of the sports medicine. Furthermore, technological advancement in the health care also accelerates the market growth.     
Europe holds the second largest share of the global market. As per the European Union Injury Database, home, leisure, and sports injuries accounted for 73% of all injuries treated every year. It is also stated that sports injuries were common among the population from 10 to 19 years of age. Furthermore, over 7.9 million children under the age of 15 are treated for an injury in European Union (EU) hospitals each year. Out of the total sports injuries, team ball sports account for 40% of all hospital-treated injuries, and the prevalence of sports injuries was found to be higher among men than women. Additionally, In the EU, muscle strains, tendonitis, and stress fracture are the common chronic sports injuries. As per the article published in the Clinics in the Orthopedic Surgery, traumatic tendon injuries are commonly treated sports injuries, especially in the emergency department of the hospital. Additionally, soccer, tennis, indoor ball games, and downhill skiing are various games resulting in Achilles tendon ruptures.  
The Asia Pacific is the fastest growing patellar tendinitis market across the globe. Japan holds a major share of the regional market due to the availability of technology and huge healthcare spending. Rapidly developing the economy, increasing healthcare expenditure, and government initiatives for research & development will drive the market in China and India over the assessment period.       
The Middle East and Africa hold the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market whereas, the African region is expected to witness a moderate growth.  

Segmentation
The global patellar tendinitis market is segmented on the basis of diagnosis, treatment, and end user. On the basis of diagnosis, it is segmented into the physical examination, imaging tests, and others. An imaging test is further segmented into X-rays, Ultrasound, and Magnetic resonance imaging (MRI).  The treatment segment is divided into corticosteroid injection, platelet-rich plasma injection, surgery, Medical devices, and others. Medical devices are further segmented into the mechanical band, support tape, pre-cut strips, continuous rolls, and others. Based on the end user, it is segmented into hospitals & clinics, research laboratories, and others.
Key Players
Some of key the players in the market are Toshiba Medical Systems Corporation (Japan), Carestream Health (U.S.), Nihon Kohden Corporation (Japan), Electrical Geodesics Inc. (U.S.), Fujifilm Holdings (Japan), GE Healthcare (U.S.), Siemens Healthcare(U.S.), Philips Healthcare (U.S.), Shimadzu Corporation (Japan), Masimo Corporation (U.S.), Hologic (U.S.), Esaote (Italy), and others.

Thursday, October 24, 2019

Mouth Ulcer Treatment Market : Key Players, Growth, Analysis by 2019 – 2023

Market Highlights
Mouth ulcers are painful sores that can develop in the mucous membrane of the oral cavity and this restrict the ability to chew, bite or eat. Some factors which result in mouth ulcer are stress, infection, injury, allergy, and others which leads to intense pain. Increasing use of synthetics in oral items such as toothpaste and growing unhealthy lifestyle, including high consumption of junk food and tobacco are some of the factors driving the growth of this market. Mouth ulcer can be prevented by avoiding tissue injury, avoiding the food that causes irritation in mouth and maintaining oral hygiene. Besides the traditional method, various drugs are used to treat mouth ulcer. Increasing aging population and increasing incidences of mouth ulcer are driving the growth of this market.
However casual approach of people towards mouth ulcer and lack of awareness about the fact that if mouth ulcer is not treated early it may lead to cancer, this factors can have a negative impact on the growth of this market.
Regional Analysis
A booming need for more oral hygiene appeal in the field of mouth ulcer treatment is being observed worldwide. The rising awareness regarding oral hygiene and increasing incidence of mouth ulcer are factors responsible for the growth of the market in this region. 
The market in the Americas is expected to boost the global mouth ulcer treatment market owing to technological advances and increasing incidences of mouth ulcer. This is largely attributed to the accessibility of an urban healthcare infrastructure. The European market is expected to be the second-largest due to government funding and support from the healthcare sector coupled with the rising prevalence of mouth ulcer. Moreover, the rising demand for mouth ulcer treatment in developing markets of Asia-Pacific have prospered the field of mouth ulcer market. The market in the Middle East and Africa accounts for the smallest share due to lack of medical technology and poor medical facilities.
Segmentation
 The global mouth ulcer treatment market has been segmented on basis of drug type, formulation, and indication. On basis of drug type, the market is segmented into corticosteroid, antihistamine, antimicrobial, analgesic, and anesthetic. Based on formulation mouth ulcer treatment market is segmented into gel, mouthwash, ointment, spray, and lozenges. Based on indication mouth ulcer treatment market is segmented into Aphthous Stomatitis, Oral Lichen Planus and Others.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
Key Players
Some of the key players in the global mouth ulcer treatment market are Pfizer, Inc., Church & Dwight Co., Inc., 3M, Taro Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, BLISTEX, INC., GlaxoSmithKline plc., ECR Pharmaceuticals, Sannova, Reckitt Benckiser, Sunstar, Blairex Laboratories, Sanjin Pharmaceutical, Joincare Pharmaceutical, Sinclair Pharma, and Colgate-Palmolive Company

Wednesday, October 23, 2019

Chinese Fibromyalgia Market : Key Players, Growth, Analysis by 2019 – 2023

Market Highlights:
Fibromyalgia syndrome co-exists with other painful conditions, such as migraine and other types of headaches, temporomandibular joint disorders, irritable bowel syndrome (IBS), and interstitial cystitis. The treatment of fibromyalgia includes both targeted and symptomatic approach. Till date, there are only three FDA approved drugs for the fibromyalgia treatment, i.e., Lyrica (PFIZER), Cymbalta (Eli Lilly and Company), and Savella (Allergan plc). However, there are few other drugs prescribed by physicians to control the symptoms of fibromyalgia such as pain relievers, muscle relaxants, and traditional Chinese medicine.
Growing geriatric population, increasing cases of rheumatic diseases, growing awareness among the population, and rising incidences of traumatic stress and road accidents are the key factors driving the Chinese fibromyalgia market. According to a study published in the Arthritis Care & Research journal in 2017, fibromyalgia and related symptoms worsen the functional status of individuals with rheumatoid arthritis. Around 15%-30% of patients with rheumatic disorders have co-morbid fibromyalgia syndrome.
However, difficulty in diagnosis of the disease, and stringent FDA regulations may hinder the growth of the market to an extent. As fibromyalgia syndrome is associated with other chronic diseases so, its diagnosis takes a long time. As fibromyalgia syndrome is associated with other chronic diseases so, its diagnosis takes a long time. According to a study published in Arthritis Research & Therapy journal in 2017, in Taiwan, the risk of coronary heart disease in fibromyalgia patients was 47% higher than the general population.

Key Players
Some of key the players in the market are Pfizer, GlaxoSmithKline, AstraZeneca, Roche, Astellas Pharma, Eli Lilly and Company, Johnson & Johnson Services, Inc., SANOFI, Bayer AG, AbbVie, ALLERGAN, Boehringer Ingelheim, Cephalon, Inc., Vertical Pharmaceuticals, Sunovion Pharms Inc, Jazz Pharmaceuticals, ABBOTT, NOVARTIS, and others.
Regional Analysis
South Central China accounted for the major share of the market owing to the rising prevalence of fibromyalgia in this region. Rising cases of chronic rheumatic diseases are also capable of fuelling the fibromyalgia market in China. Prevalence of rheumatoid arthritis is around 0.35%, with the significantly higher rate in Northern China as compared to the Southern part.
The rising healthcare expenditure is also propelling the growth of the market. In China, the total expenditure on health per capita in 2014 was USD 731, as per the World Health Organization (WHO) in 2015. The health expenditure in China grew at a rate of 11.6% per year, suggested by a study published in BMC Health Services Research journal in 2017. This rate is much faster than the growth of the country’s economy, i.e., 9.9% per year.
Segmentation
The Chinese fibromyalgia market is segmented on the basis of diagnosis, treatment, and end-user.
On the basis of the diagnosis, the market is classified into laboratory evaluation and presence of central sensitization.
On the basis of the treatment, the market is segmented into targeted treatment and symptomatic treatment.
On the basis of the end-users, the market is segmented into hospitals, clinics, diagnostic centers, and others.

Pipettes, Pipettors, and Accessories Market : In-Depth Market Research Report 2019 – 2023


Market Highlights:
The Global Pipettes, Pipettors and Accessories Market held a market value of USD 1,350.0 million in 2017 and is projected to grow at a CAGR of 4.1% over the forecast period. A pipette is a laboratory tool used in laboratories to transfer a measurable amount of liquid from one container to another. These are small tubes or slender graduated tubes of glass or plastic used in laboratories to transfer a measurable volume of liquid. A pipettor is an instrument used to dispense liquid while pipetting. This instrument allows remote operation of a pipette, usually by the attachment of an extension tube. Factors characterizing the market growth are rising investment in research and development (R&D) activities, increasing demand for accuracy, productivity, and quality, growing focus on improving lab throughputs, and mounting applications in life sciences and biomedical research, pharmaceutical, environmental, chemical, and food processing industries. For instance, on 20 December 2018, the Cancer Institute (WIA), an Indian non-profit cancer treatment and research center launched India’s first molecular lab for cervical cancer screening. In addition, on 10 December 2018, AstraZeneca plc collaborated with Cancer Research UK to launch a center of excellence in genetic screening, cancer modelling and big data processing in order to accelerate the discovery of novel cancer medicines in the UK.
Regional Analysis:
The Global Pipettes, Pipettors and Accessories Market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. On the basis of region, the Americas is likely to dominate the global pipettes, pipettors, and accessories market owing to the increasing biotechnology and pharmaceutical R&D activities and the presence of major market players in the U.S. and Canada. In November 2018, the US Food and Drug Administration (US FDA) emphasized on improved outcomes and R&D over the biotech industry due to the expiry of more than 25 drugs patents.Europe will hold the second largest market position during the forecast period due to the availability of developed lab facilities, the number of key market participants headquartered, and the presence of sophisticated healthcare infrastructure.
 The market in Asia-Pacific is anticipated to display comparatively higher CAGR during the forecast period owing to growing awareness and increasing interest in scientific & industrial research in order to create new business opportunities in India, China, Japan, and Australia.The Middle East & Africa has the least share of the global pipettes, pipettors, and accessories market. Additionally, the major market share of the region would be held by the Middle East region attributed to gradually rising adoption of laboratory supplies or equipment in the GCC region.

Segmentation:
The Global Pipettes, Pipettors and Accessories Market has been segmented into product and end user.By product, the market has been segmented into pipettes, pipettors, and accessories. The pipettes segment is further categorized into beral/plastic/transfer/disposable pipettes, pasteur/glass pipettes/droppers, serological pipettes, volumetric/bulb pipettes, and others. The pipettors segment is sub-segmented into electronic pipettors and manual pipettors. These two pipettors are further separately categorized into single-channel pipettors and multichannel pipettors.Based on end user, the market has been segmented into hospitals, laboratories, academic & research institutes, pharmaceutical & biotechnology companies, and others.
Key Players:
Some of the leading players in the Global Pipettes, Pipettors and Accessories Market are Thermo Fisher Scientific Inc., Thomas Scientific, Inc., BRAND GMBH + CO KG, CAPP ApS, Corning Incorporated, Hamilton Company, Eppendorf AG, Gilson Incorporated, Greiner Bio-One International GmbH, INTEGRA Biosciences AG, The Lab Depot, Inc., Sartorius AG, Socorex Isba S.A., Nichiryo Co.,Ltd., and Mettler-Toledo International Inc.


Tuesday, October 22, 2019

Neonatal Thermoregulation Market : Key Players, Growth, Analysis by 2019 – 2023

Market Highlights:
It is estimated that the Global Neonatal Thermoregulation Market is expected to hold a market value of USD 500 million and register a CAGR ~ 5.0 % during the forecast period of 2018–2023. Thermoregulation is the ability to create equilibrium between heat production and heat loss in order to maintain body temperature within a certain normal range. The provision of a thermoneutral environment is an essential component of the immediate and long-term care of newborn infants. With the surge in the birth rates of newborns, the equipment used for blood sampling and monitoring the baby is steadily increasing. According to a data published by the Centers for Disease Control and Prevention in January 2017, there were 3,945,875 births in the US in 2017. This means birth rate in US in 2017 was 12.2 per 1000 population. Moreover, rising prevalence of diseases in neonates fuels the growth of the market. However, stringent government regulation for product approval and possible side-effects for the neonates may hamper the market growth during the assessment period.
The global neonatal thermoregulation market is currently dominated by many market players. The key players in the market are engaged in new product launches and strategic collaborations to strengthen its market position. For instance, in November 2016, Drägerwerk AG & Co. KGaA introduced IncuWarmer Babyleo TN500 which offers optimal thermoregulation in open care, closed care and transition to the premature baby.
Regional Analysis:
The Americas is anticipated to dominate the global neonatal thermoregulation market owing to a well-developed healthcare sector, and rising prevalence of diseases. The involvement of government in creating awareness about the neonatal diseases also fuels the growth of the market. For instance, US government has programs like Screening Quality Assurance Programs and Heritable Disorders Program at Health Resources and Service Administration (HRSA). Thus, such initiatives and programs by the government as well as non-government organizations support the market growth. Europe is expected to hold the second largest position in the global neonatal thermoregulation market. The market growth in this region is attributed to the availability of funds for research. Asia-Pacific is anticipated to be the fastest growing region in the market due to the presence of a huge patient population, and continuously developing economies, According to a report published by the International Journal of Social and Developmental Concerns in October 2017, in Malaysia, growth of the public primary as well as secondary care facilities has decreased in the past few years and it has not kept pace with the rapid urbanization. Thus, such factors restraint the growth of the market in this region. On the other hand, the Middle East & Africa has the least share of the market.

Monday, October 21, 2019

Sleep Testing Services Market Research Forecast, Regional, Trends and Analysis to 2023

Market Highlights
The global sleep testing services market is anticipated to hold a market value of USD 5.9 billion in the year 2017 and is expected to grow at a CAGR of 13.2% during the forecast period. Sleep testing services are used to diagnose sleep disorders by recording heart rate, breathing patterns, brain waves, eye movements, leg movements, etc.
Rising prevalence of sleep disorders, increasing awareness about sleep testing services and technological advancements related to sleep testing services are expected to drive the growth in the market over the forecast period. According to an article published in the Psychiatry Research magazine by Science Direct published in July 2018, global prevalence of restless leg syndrome (a sleep disorder) is 14.8%.  However, high costs of the sleep testing services can restrain the market growth over the assessment period.
Regional Analysis
Geographically, the Americas is expected to dominate the global market owing to the high prevalence of various sleep disorders, rising awareness about the sleep testing services. According to an article published by the National Institute of Neurological Disorders and Stroke in July 2018, 135,000 to 200,000 people in the US are affected by narcolepsy, which is a disorder that affects the sleep-wake cycle of a person. Europe is expected to hold the second largest position in the global market owing to the increasing awareness about sleep testing services. Asia-Pacific is expected to be the fastest growing market owing to the rising prevalence of sleep disorders like insomnia, restless leg syndrome, etc. Moreover, the Middle East and Africa region is expected to account for the least market share in the global market.
Segmentation
The global sleep testing services market has been segmented into diagnostic services, treatment monitoring services and end user.
The market, on the basis of diagnostic services, has been segmented into home sleep testing and in-lab sleep testing. In-lab sleep testing is further segmented into electroencephalogram, full polysomnography, CPAP/BiPAP Titration, multiple sleep latency test (MSLT) and maintenance of wakefulness test (MWT).
The global market, on the basis of treatment monitoring services, has been segmented into obstructive sleep apnea, insomnia, restless legs syndrome, circadian rhythm disorders, narcolepsy and rapid eye movement (REM) sleep disorder.
The global sleep testing services market, by end user, has been segmented into hospitals, sleep centers, home care settings and others. The hospitals segments is expected to hold the largest market share owing to high preference of people visiting the hospitals for treating their disorders. Whereas the sleep centers are expected to grow at the fastest market share owing to increasing awareness among patients regarding the sleep centers.
Key Players
Some of the prominent players in the global sleep testing services market are St. Luke's, Medical Service Company, Midwest Sleep Diagnostics, Inc., Sleep Services Australia, Total Sleep Holdings, Inc., GenesisCare, Carolinas Sleep Services, SleepMed, SOVA Sleep Services, SleepWorks, LLC, HomeSleep, LLC and Others.

Friday, October 18, 2019

Bronchitis Market Size Growing Growth Opportunities, Driving Factors With Top Players 2019


Market Highlights
The infection in the airways of lungs (bronchi) is known as bronchitis, which is of two types, namely, acute and chronic bronchitis. Acute bronchitis resolves within two to three weeks while chronic bronchitis is the condition when a cough exists for at least three months and at least two years in a row. Smoking, viruses such as flu and bacteria, inhalation of irritating fumes or dust are the major causes of chronic bronchitis. Chest X-ray, sputum tests, and pulmonary function tests are various tests performed for the diagnosis of acute as well as chronic bronchitis.
High prevalence of lung diseases such as Chronic Obstructive Pulmonary Disease (COPD), bronchitis, asthma, and others are the major factor driving the growth of the market. Further, there is a huge demand for diagnostic tests for bronchitis and other lung diseases. The treatment includes administration of drugs such as antibiotics, anti-inflammatory drugs, bronchodilators, and mucolytics.
The Global Bronchitis Market is Expected to grow at a CAGR of 5.3% during the forecast period.
Taste the market data and market information presented through more than 55 market data tables and figures spread over 101 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Bronchitis market research report–Global forecast till 2023.”
Major Players in the Bronchitis Market:
Some of the key players in the global market are GlaxoSmithKline Pharmaceuticals Limited, Boehringer Ingelheim, Dr. Reddy’s Laboratories Ltd, Pfizer Inc., Sanofi, Cathay Drug Company Inc., Kaiser Permanente Inc., AstraZeneca, and others.
Regional Analysis
The market for bronchitis is found to be increasing in Americas, which is driven by growing awareness about risk factors of COPD and bronchitis and rising emphasis on healthy lifestyle and prevention of lung diseases. In the U.S., the bronchitis market is fueled by the presence of major market players and extensive use of diagnostic services. The rapid growth in diagnostic and treatment services also accelerates the growth of the market.
In Europe, the major factors accelerating the market are extensive research and development in the field of respiratory diseases and increase in the number of players in the market manufacturing drugs for the treatment of diseases. Germany is the largest contributor to the market growth.
In Asia Pacific, the market is driven by the rising prevalence of chronic diseases including respiratory diseases and increasing environmental pollution.
In the Middle East and Africa, rising awareness about lung diseases among adults and development of the healthcare sector drive the growth of the market.

Segmentation
The global bronchitis market is segmented on the basis of type, diagnosis, treatment, and end-user.
On the basis of type, the market is segmented into acute bronchitis and chronic bronchitis.
On the basis of diagnosis, the market is segmented into chest X-ray, sputum tests, and pulmonary function tests.
On the basis of treatment, the market is segmented into drugs and oxygen therapy. Drugs is further segmented into antibiotics, anti-inflammatory drugs, bronchodilators, and mucolytics.
On the basis of end-user, the market is segmented into hospitals, clinics, pharmacies, research institutes, and others.